Levothyroxine Recall; Klotho & Osteoporosis Protection; Marriage for a Lower HbA1c?

The FDA announced a nationwide recall of 27 lots of IBSA Pharma’s levothyroxine sodium oral solution (Tirosint-SOL) due to subpotency.

Children conceived using assisted reproductive technology (ART) had no significant differences in blood pressure, heart rate, lipids, and glucose levels compared with naturally conceived babies, a meta-analysis revealed. HDL and LDL cholesterol were the only measures significantly higher in ART-conceived children. (European Heart Journal)

Higher levels of the bone mineral density-related protein Klotho in postmenopausal women were associated with a significantly lower prevalence of osteoporosis, found a retrospective study published on the preprint server Research Square.

Are medical schools failing on obesity training? (NPR)

Developer Sandoz said it’s seeking FDA approval of a biosimilar to denosumab (Prolia, Xgeva) for treating postmenopausal osteoporosis.

A third of patients with overweight or obesity and type 2 diabetes lost at least 5% of their body weight using a GLP-1 receptor agonist for 72 weeks, a real-world study found. (Obesity)

Looking for another way to maintain a lower HbA1c? Try getting married. (BMJ Open Diabetes Research & Care)

Yet another study found gender dysphoria in transgender children and adolescents was linked with poorer quality of life, depression, and anxiety when compared with peers. (JAMA Network Open)

The U.S. Department of Agriculture announced new nutrition standards for schools, which if enacted would curb sugar and sodium and boost whole grains. (NPR)